相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。p53: An Attractive Therapeutic Target for Cancer
Krupa R. Patel et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction
Ewa Surmiak et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
The 1,2,3-triazole ring as a bioisostere in medicinal chemistry
Elisa Bonandi et al.
DRUG DISCOVERY TODAY (2017)
How To Design a Successful p53-MDM2/X Interaction Inhibitor: A Thorough Overview Based on Crystal Structures
Natalia Estrada-Ortiz et al.
CHEMMEDCHEM (2016)
Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Ramandeep Kaur et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al.
HUMAN MUTATION (2016)
Thioimidazoline based compounds reverse glucocorticoid resistance in human acute lymphoblastic leukemia xenografts
Cara E. Toscan et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction
Mariell Pettersson et al.
PLOS ONE (2015)
An overview of targeted cancer therapy
Viswanadha Vijaya Padma
BIOMEDICINE-TAIWAN (2015)
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
Stefan Zimmermann et al.
CANCER TREATMENT REVIEWS (2014)
Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 1
Weisi Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53-MDM2 Protein-Protein Interaction
Chunlin Zhuang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
Marcelo Zaldini Hernandes et al.
CURRENT DRUG TARGETS (2010)
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field
Devleena Shivakumar et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2010)
Identifying and Characterizing Binding Sites and Assessing Druggability
Thomas A. Halgren
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Coping with stress: multiple ways to activate p53
H. F. Horn et al.
ONCOGENE (2007)
Nongenotoxic p53 activation protects cells against S-phase-specific chemotherapy
Dominique Kranz et al.
CANCER RESEARCH (2006)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction
Ke Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
1,4-benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR
DJ Parks et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
A hierarchical approach to all-atom protein loop prediction
MP Jacobson et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy
P Chène
NATURE REVIEWS CANCER (2003)
Prediction of drug solubility from structure
WL Jorgensen et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
分享论文
